Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K1AI
|
|||
| Former ID |
DIB009761
|
|||
| Drug Name |
Sch-58500
|
|||
| Synonyms |
ACN-53; ACN-p53 TSG, Canji/Schering-Plough; Gene therapy (p53), Canji/Schering-Plough; RAd/p53, Canji/Schering-Plough
Click to Show/Hide
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 1 | [1] | |
| Company |
Canji Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00002960) SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.